A statement released by the Advanced Medical Technology Association (AdvaMed) illustrates medical gadget brings to mind in Europe and the U.S. happen at about no different rate, although the endorsement procedure in the U.S. takes considerably longer.

Stephen J. Ubl, AdvaMed President and CEO said, “It’s well-documented that it gets longer to carry medical technology to market in the U.S. than it does in Europe. The report recommends that the postponement denies patients access to the most modern treatments and cures without an equivalent boost in protection.”

The statement looks at the rate of security remember for medical . . . → Read More: Medical Gadget Recalls in US and Europe at Similar Rates